Irritable Bowel Syndrome (IBS)ReferencesCitationsRingel Y, et al. (2001). Irritable bowel syndrome.
Annual Review of Medicine, 52: 319–338. Read NW (2002). Irritable bowel syndrome. In M
Feldman et al., eds., Sleisenger and Fordtran's
Gastrointestinal and Liver Disease, 7th ed., vol. 2, pp. 1794–1806.
Philadelphia: W.B. Saunders. Mertz HR (2003). Irritable bowel syndrome.
New England Journal of Medicine, 349(22):
2136–2146. Thompson WG, et al. (2000). Irritable bowel syndrome
section of Functional bowel disorders and functional abdominal pain. In DA
Drossman et al., eds., Rome II: The Functional Gastrointestinal
Disorders, 2nd ed., pp. 355–375. McLean, VA: Degnon
Associates. Thompson WG, et al. (1999). Functional bowel disorders
and functional abdominal pain. Gut, 45(Suppl II):
II43–II47. American College of Gastroenterology Functional
Gastrointestinal Disorders Task Force (2002). Evidence-based position statement
on the management of irritable bowel syndrome in North America. American Journal of Gastroenterology, 97(11, Suppl):
S1–S26. Olden KW (2002). Diagnosis of irritable bowel
syndrome. Gastroenterology, 122(6):
1701–1714. Holten KB, Wetherington A (2003). Diagnosing the
patient with abdominal pain and altered bowel habits: Is it irritable bowel
syndrome? American Family Physician, 67(10):
2157–2162. Hasler WL (2002). The irritable bowel syndrome.
Medical Clinics of North America, 86:
1525–1551. American Gastroenterological Association (2002).
American Gastroenterological Association medical position statement: Irritable
bowel syndrome. Gastroenterology, 123(6):
2105–2107. Talley NJ (2000). Treatment of the irritable bowel
syndrome. In MM Wolfe et al., eds., Sleisenger and Fordtran's
Therapy of Digestive Disorders, pp. 477–490. Philadelphia: W.B.
Saunders. Spanier JA, et al., (2003). A systematic review of
alternative therapies in the irritable bowel syndrome. Archives
of Internal Medicine, 163: 265–274. Marteau PR, et al. (2001). Protection from
gastrointestinal diseases with the use of probiotics. American
Journal of Clinical Nutrition, 73(2, Suppl 1): 430S–436S. Sharara AI, et al. (2006). A randomized
double-blind placebo-controlled trial of rifaximin in patients with abdominal
bloating and flatulence. American Journal of
Gastroenterology, 101(2): 326–333.
Other Works ConsultedAmerican Gastroenterological Association (2002).
American Gastroenterological Association medical position statement: Irritable
bowel syndrome. Gastroenterology, 123(6):
2105–2107. Friedel D, et. al. (2001). Ischemic colitis during
treatment with alosetron. Gastroenterology, 120(2):
557–560.
| |